<div id="readability-page-1"><div><p><span>Cross Shawn Chief Financial Officer of Pacira BioSciences Inc [PCRX] filed a Form 4 on December 11, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><th><span>Date</span></th><th><span>Transaction</span></th><th><span>Shares</span></th><th><span>Price</span></th><th><span>Value</span></th></tr><tr><td><span>12/9/25-12/10/25</span></td><td><span>Planned Exercise(1)(2)</span></td><td><span>25,000</span></td><td><span>$16.45</span></td><td><span>$411,250</span></td></tr><tr><td><span>12/9/25-12/10/25</span></td><td><span>Planned Sale(2)</span></td><td><span>25,000</span></td><td><span>$25.07</span></td><td><span>$626,753</span></td></tr></tbody></table></div><p><span>Ending Holdings: 56,250 - Direct</span></p><div><table><tbody><tr><td><span>(1)</span></td><td><span>Exercised 8.9 years before expiration date.</span></td></tr><tr><td><span>(2)</span></td><td><span>Executed pursuant to a prearranged trading plan (10b5-1).</span></td></tr></tbody></table></div><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

PCRX

<p>Shawn Cross, CFO of Pacira BioSciences Inc, disclosed a transaction involving the exercise and sale of 25,000 shares, valued at $626,753, under a prearranged trading plan. The transaction was filed with the SEC on December 11, 2025. Cross's ending holdings are 56,250 shares.</p>

CFO Cross Sells 25,000 ($626.8K) Of Pacira BioSciences Inc [PCRX]